Aquaporins: Important players in the cardiovascular pathophysiology.
AER-271 (PubChem CID:10412080)
Aquaporin
Bacopaside(PubChem CID:21599442)
Bumetanide (PubChem CID:2471)
Cardiovascular system
Chemical compounds studied in this article Acetazolamide (PubChem CID:1986)
HAuCl4 (PubChem CID:10925836)
LiCl (PubChem CID: 433294)
Localization
Methylene blue (PubChem CID:6099)
Modulators
Pathophysiology
Phloretin (PubChem CID:4788)
Quercetin (PubChem CID:5280459)
TGN-020 (PubChem CID:4173511)
Journal
Pharmacological research
ISSN: 1096-1186
Titre abrégé: Pharmacol Res
Pays: Netherlands
ID NLM: 8907422
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
received:
06
05
2022
revised:
20
07
2022
accepted:
22
07
2022
pubmed:
30
7
2022
medline:
14
9
2022
entrez:
29
7
2022
Statut:
ppublish
Résumé
Aquaporin is a membrane channel protein widely expressed in body tissues, which can control the input and output of water in cells. AQPs are differentially expressed in different cardiovascular tissues and participate in water transmembrane transport, cell migration, metabolism, inflammatory response, etc. The aberrant expression of AQPs highly correlates with the onset of ischemic heart disease, myocardial ischemia-reperfusion injury, heart failure, etc. Despite much attention to the regulatory role of AQPs in the cardiovascular system, the translation of AQPs into clinical application still faces many challenges, including clarification of the localization of AQPs in the cardiovascular system and mechanisms mediating cardiovascular pathophysiology, as well as the development of cardiovascular-specific AQPs modulators.Therefore, in this study, we comprehensively reviewed the critical roles of AQP family proteins in maintaining cardiovascular homeostasis and described the underlying mechanisms by which AQPs mediated the outcomes of cardiovascular diseases. Meanwhile, AQPs serve as important therapeutic targets, which provide a wide range of opportunities to investigate the mechanisms of cardiovascular diseases and the treatment of those diseases.
Identifiants
pubmed: 35905892
pii: S1043-6618(22)00308-5
doi: 10.1016/j.phrs.2022.106363
pii:
doi:
Substances chimiques
Aquaporins
0
Water
059QF0KO0R
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
106363Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.